Home › Hemophilia B › Michigan
Pag-aaral pangklinika para sa Hemophilia B sa Michigan
6 pag-aaral para sa Hemophilia B ang naghahanap ng mga kalahok sa mga site sa Michigan.
Mga Lungsod sa Michigan
Opisyal na teksto ng pag-aaral (English)
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
- University of Michigan Medical Center, Ann Arbor
Nagre-recruitPhase 3
138 Months – 206 Months · Kalalakihan · Na-update Set 16, 2026 · NCT07080905A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
- University of Michigan, Ann Arbor
Nagre-recruitPhase 1/2
Edad 2 pataas · Kalalakihan · Na-update Set 11, 2026 · NCT06379789Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
- University of Michigan, Ann Arbor
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT06003387ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Central Michigan Children's Hospital of Michigan, Detroit
- Henry Ford Health System Bleeding and Thrombosis Treatment Center, Detroit
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04398628A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
- University of Michigan Hospitals - Michigan Medicine, Ann Arbor
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT06349473SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Children's Hospital of Michigan, Detroit
- Henry Ford Health System, Detroit
- MSU Center for Bleeding and Clotting Disorders, Lansing
Nagre-recruitPhase 4
Edad 12 hanggang 100 · Lahat ng kasarian · Na-update Ene 12, 2026 · NCT04647227Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.